Union Health Minister J.P. Nadda launched of the second version of the National Action Plan on Antimicrobial Resistance (NAP-AMR) (2025–29). File photo: X/@MoHFW_INDIA
Antimicrobial Resistance (AMR) is a major public health concern and poses significant risks, particularly in surgical procedures, cancer treatment, and other critical healthcare interventions.
It can be addressed only through collective action, Union Health Minister J. P. Nadda said on Tuesday (November 18, 2025), at the launch of the second version of the National Action Plan on Antimicrobial Resistance (NAP-AMR) (2025–29).
“Overuse and misuse of antibiotics have unfortunately become common practice, and NAP-AMR 2.0 addresses the gaps identified in the first plan by increasing the ownership of AMR-related efforts, strengthening inter-sectoral coordination and ensuring stronger engagement with the private sector,’’ he said, adding that there is a requirement of enhancing laboratory capacity and infection control in healthcare facilities.
AMR has been identified as a global health threat with serious health, political and economic implications. It leads to delays in treatment, increasing the risk of spreading resistant microorganisms, and adds to healthcare costs and the economic burden to families and societies.
Published – November 18, 2025 07:48 pm IST
